To Evaluate the Safety, Tolerability, and Pharmacokinetics Profile in Healthy Chinese Volunteers of TG-2349
Status:
Completed
Trial end date:
2017-08-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK)
profile of different doses of TG-2349 (Furaprevir capsule) in healthy Chinese volunteers.